Liver CYP4A autophagic lysosomal degradation: A major role for the autophagic receptor SQSTM1/p62 through an uncommon target interaction site.

Saved in:
Bibliographic Details
Title: Liver CYP4A autophagic lysosomal degradation: A major role for the autophagic receptor SQSTM1/p62 through an uncommon target interaction site.
Authors: He L; Department of Cellular & Molecular Pharmacology, University of California San Francisco, San Francisco, California., Kwon D; Department of Cellular & Molecular Pharmacology, University of California San Francisco, San Francisco, California., Trnka MJ; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California., Liu Y; Department of Cellular & Molecular Pharmacology, University of California San Francisco, San Francisco, California., Yang J; Department of Medicinal Chemistry, University of Washington, Seattle, Washington., Li KH; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California., Totah RA; Department of Medicinal Chemistry, University of Washington, Seattle, Washington., Johnson EF; Department of Molecular Medicine, Scripps Research Institute, La Jolla, California., Burlingame AL; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California., Correia MA; Department of Cellular & Molecular Pharmacology, University of California San Francisco, San Francisco, California; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California; The Liver Center, University of California San Francisco, San Francisco, California. Electronic address: almira.correia@ucsf.edu.
Source: Molecular pharmacology [Mol Pharmacol] 2025 Sep; Vol. 107 (9), pp. 100061. Date of Electronic Publication: 2025 Jul 11.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0035623 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-0111 (Electronic) Linking ISSN: 0026895X NLM ISO Abbreviation: Mol Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1521-0111
DOI:10.1016/j.molpha.2025.100061